Table 7.
SNP | Model | Genotype | Adenocarcinoma | Squamous Cell Carcinoma | Small Cell Lung Cancer | |||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p | |||
rs10981694 | Dominant | TT | 1 | 0.048 | 1 | 0.0001* | 1 | 0.024 |
TG-GG | 1.35 (1.00–1.81) | 2.06 (1.44–2.96) | 1.67 (1.07–2.59) | |||||
Recessive | TT-TG | 1 | 0.027 | 1 | 0.07 | 1 | 0.015 | |
GG | 2.31 (1.11–4.83) | 2.21 (0.96–5.09) | 3.26 (1.34–7.93) | |||||
Log-additive | — | 1.37 (1.07–1.77) | 0.014 | 1.86 (1.38–2.53) | 0.0001* | 1.70 (1.18–2.46) | 0.005* | |
rs10488764 | Dominant | GG | 1 | 0.0021* | 1 | 0.0098 | 1 | 0.0006* |
GA-AA | 1.55 (1.17–2.05) | 1.53 (1.11–2.12) | 2.00 (1.34–2.96) | |||||
Recessive | GG-GA | 1 | 0.22 | 1 | 0.0006* | 1 | 0.058 | |
AA | 1.42 (0.82–2.45) | 2.70 (1.56–4.68) | 1.97 (1.01–3.85) | |||||
Log-additive | — | 1.40 (1.12–1.75) | 0.003* | 1.56 (1.22–2.00) | 0.0005* | 1.72 (1.27–2.31) | 0.0005* | |
rs9535826 | Dominant | TT | 1 | 0.0013* | 1 | 0.18 | 1 | 0.0048* |
TG-GG | 0.63 (0.47–0.83) | 0.80 (0.57–1.11) | 0.56 (0.38–0.84) | |||||
Recessive | TT-TG | 1 | 0.006* | 1 | 0.29 | 1 | 0.015 | |
GG | 0.54 (0.34–0.85) | 0.77 (0.47–1.26) | 0.44 (0.22–0.91) | |||||
Log-additive | — | 0.67 (0.54–0.83) | 0.0002* | 0.83 (0.65–1.06) | 0.13 | 0.60 (0.44–0.82) | 0.0011* | |
rs9535828 | Dominant | GG | 1 | <0.0001* | 1 | 0.0022* | 1 | <0.0001* |
GA-AA | 0.46 (0.33–0.64) | 0.52 (0.34–0.79) | 0.36 (0.22–0.59) | |||||
Recessive | GG-GA | 1 | 0.0041* | 1 | 0.0035* | 1 | 0.049 | |
AA | 0.55 (0.36–0.84) | 0.48 (0.28–0.80) | 0.53 (0.27–1.03) | |||||
Log-additive | — | 0.55 (0.43–0.71) | <0.0001* | 0.52 (0.38–0.72) | <0.0001* | 0.46 (0.31–0.67) | <0.0001* |
Note: *Bonferroni multiple adjustment was applied, with p ≤ 0.008.
Abbreviations: SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence interval.